Ambalal Sarabhai Enterprises
37.30
+1.67(+4.69%)
Market Cap₹285.84 Cr
PE Ratio15.21
IndustryHealthcare
Company Performance:
1D+4.69%
1M+17.48%
6M+14.95%
1Y+14.95%
5Y+14.95%
View Company Insightsright
More news about Ambalal Sarabhai Enterprises
27Oct 25
Ambalal Sarabhai's Telerad Division Clinches Top Broadcast Award at Industry Show
Ambalal Sarabhai Enterprises Limited's Telerad division, operating under Systronics India Limited, has been awarded the 'Best Regional Distributor — Broadcast - West Award' at the Broadcast India Show 2025 in Mumbai. Telerad, a leading system integrator in the broadcast industry, is recognized for providing comprehensive end-to-end solutions across various broadcast segments. This award highlights Telerad's leadership in innovative broadcast solutions and its strong presence in western India.
 no imag found
13Aug 25
Ambalal Sarabhai Enterprises Reports Stellar Q1 Performance with 2270% Profit Surge
Ambalal Sarabhai Enterprises (ASE) reported a consolidated net profit of Rs. 822.35 lakhs for Q1, a 2270% increase from Rs. 34.71 lakhs in the same quarter last year. Revenue from operations slightly decreased by 0.88% to Rs. 4,033.88 lakhs. The company's pharmaceuticals segment generated Rs. 2,546.42 lakhs, while electronics contributed Rs. 1,487.46 lakhs. On a standalone basis, profit after tax grew by 1391% to Rs. 690.85 lakhs. ASE's Board of Directors formed a new Pharma Committee to oversee pharmaceutical operations, compliance, and business performance.
 no imag found
1 Year Returns:+14.95%
Industry Peers
Sun Pharmaceutical
1,789.90
(-0.37%)
Divis Laboratories
6,533.00
(-0.31%)
Torrent Pharmaceuticals
4,317.90
(-0.75%)
Cipla
1,379.30
(-0.79%)
Zydus Life Science
1,078.30
(-1.18%)
Dr Reddys Laboratories
1,274.00
(-1.27%)
Lupin
2,249.80
(-0.58%)
Mankind Pharma
2,299.00
(-0.91%)
Aurobindo Pharma
1,429.20
(-0.31%)
Laurus Labs
1,382.60
(-0.42%)